Abstract Submission

The American College of Rheumatology and Association of Rheumatology Health Professionals invite you to submit an abstract to the 2018 ACR/ARHP Annual Meeting and take advantage of the opportunity to have your work peer reviewed by experts in the field.

2018 Abstract Submission

Abstract submission opens April 10.

The ACR seeks abstracts on the following topics:

  • Clinical practice of rheumatology
  • Teaching of rheumatology
  • Basic and translational science that contributes to the understanding of disease pathogenesis
  • Mechanisms and efficacy of therapeutics
  • Delivery of healthcare to patients with musculoskeletal and rheumatic disease

The ARHP program is planned to reflect the needs of healthcare professionals who share an interest in rheumatology-related issues by providing a forum to address topics of professional significance with a multidisciplinary audience.

Abstract Submission Eligibility

Who Is Eligible to Submit an Abstract
Members and non-members of the ACR and ARHP are eligible to submit an abstract.

Types of Abstracts that are Eligible for Submission
Abstracts that describe original basic and clinical science related to the broad area of rheumatic diseases may be submitted.

If the abstract reports results of a clinical trial, you will be required to identify the trial phase.

Any work with human or animal subjects reported in submitted abstracts must comply with the guiding principles for experimental procedures in the World Medical Association Declaration of Helsinki.

Types of Abstracts that are Not Eligible for Submission

  • Abstracts that report work that has been accepted for publication as a manuscript (e.g., full-length article, brief report, case report, concise communication or letter to the editor, etc.) prior to the ACR/ARHP submission deadline of June 5, 2018 at noon ET are ineligible for consideration.
  • Abstracts should not report results that have been previously presented at an ACR/ARHP Annual Meeting.
  • Multiple abstracts may not be submitted for one study.
  • Abstracts submitted for the ARHP program may not be concurrently submitted to the ACR program.
  • Abstracts that appear as more than one version of a single study will be rejected.
  • Case reports are not considered appropriate and will not be reviewed.
  • Abstracts not accepted by the main abstract review deadline should not be re-submitted to the late-breaking category.

Abstract Submission Guidelines

Abstract submission guidelines will be available in March.

Abstract Submission Timeline

The 2018 abstract submission period is April 10 - June 5.

Abstract Withdrawal

After the abstract submission period closes on June 5, presenting authors may submit a request to have an abstract withdrawn.

Withdrawal requests must be submitted by the presenting author by email to withdrawn@rheumatology.org and include the following:

  • Abstract ID number
  • Abstract title
  • Presenting author’s name

Removal of a withdrawn abstract from the online supplement of Arthritis & Rheumatology cannot be guaranteed if the request is received after August 16, 2018.

Withdrawal or rejection of an abstract will not result in the refund of a submission fee. All submission fees are non-refundable.